Chevy Chase Trust Holdings LLC Invests $227,000 in Ascentage Pharma Group International – Unsponsored ADR $AAPG

Chevy Chase Trust Holdings LLC acquired a new position in Ascentage Pharma Group International – Unsponsored ADR (NASDAQ:AAPG) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 5,753 shares of the company’s stock, valued at approximately $227,000.

Separately, Monashee Investment Management LLC acquired a new stake in shares of Ascentage Pharma Group International in the first quarter worth $3,511,000.

Ascentage Pharma Group International Price Performance

Shares of Ascentage Pharma Group International stock opened at $34.46 on Wednesday. The firm has a fifty day simple moving average of $40.06 and a 200-day simple moving average of $34.03. The company has a debt-to-equity ratio of 1.31, a quick ratio of 1.53 and a current ratio of 1.54. Ascentage Pharma Group International – Unsponsored ADR has a 1-year low of $16.50 and a 1-year high of $48.45.

About Ascentage Pharma Group International

Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.